Company Filing History:
Years Active: 2019
Title: Albert Gubern-Mérida: Innovator in Digital Breast Tomosynthesis
Introduction
Albert Gubern-Mérida is a notable inventor based in Den Bosch, Netherlands. He has made significant contributions to the field of medical imaging, particularly in the area of digital breast tomosynthesis (DBT). His work focuses on improving the visualization and analysis of breast imaging data, which is crucial for early detection and diagnosis of breast cancer.
Latest Patents
Gubern-Mérida holds a patent for a displaying system designed for displaying digital breast tomosynthesis data. This invention relates to a system that provides first and second DBT volume images of both the left and right breasts of a woman. The system includes a navigation image that allows users to indicate a location, after which a computer-aided detection (CAD) marker associated with that location is determined in the DBT volume images. The slices of these images, linked to the CAD markers, are then presented on a display, enhancing the diagnostic capabilities of healthcare professionals.
Career Highlights
Albert Gubern-Mérida is currently associated with Screenpoint Medical, a company that specializes in advanced imaging solutions for breast cancer detection. His work at Screenpoint Medical has been instrumental in developing innovative technologies that improve the accuracy and efficiency of breast imaging.
Collaborations
One of his notable collaborators is Nico Karssemeijer, who shares a commitment to advancing medical imaging technologies. Their partnership has contributed to the development of effective solutions in the field of breast cancer diagnostics.
Conclusion
Albert Gubern-Mérida's contributions to digital breast tomosynthesis represent a significant advancement in medical imaging technology. His innovative patent and collaboration with industry experts continue to enhance the capabilities of breast cancer detection and diagnosis.